Abstract
Chemotherapy-related cognitive impairment, also known as Chemobrain or chemotherapy fog, is a clinical condition characterized by a cognitive deficit that mainly compromises short-term memory and the ability to concentrate. It is currently estimated that up to 75% of cancer patients suffer from some measure of cognitive alterations, and the lack of understanding of the molecular mechanism…